Kyverna Therapeutics, Inc. · NASDAQ:KYTX
Kyverna Therapeutics, Inc. shareholders
As of Sep 30, 2026, 121 institutions reported holding Kyverna Therapeutics, Inc., 55.6% of its shares. Largest: GordonMD Global Investments LP, Gilead Sciences, Inc. and AIGH Capital Management LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Kyverna Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| GordonMD Global Investments LP | 4.52M | 7.2% | +277K | Nov 16, 2026 |
| Gilead Sciences, Inc. | 4.13M | 6.5% | no change | Nov 5, 2026 |
| AIGH Capital Management LLC | 3.65M | 5.8% | +854K | Nov 2, 2026 |
| BlackRock | 3.24M | 5.1% | +103K | Nov 13, 2026 |
| Vanguard | 2.67M | 4.2% | +202K | Nov 16, 2026 |
| Bain Capital Life Sciences Investors, LLC | 1.31M | 2.1% | −1.57M | Nov 16, 2026 |
| T. Rowe Price | 1.21M | 1.9% | +21,541 | Nov 16, 2026 |
| State Street | 1.2M | 1.9% | +221K | Nov 12, 2026 |
| Geode Capital | 1.05M | 1.7% | +4,251 | Nov 6, 2026 |
| Insight Holdings Group, LLC | 989K | 1.6% | no change | Nov 16, 2026 |